Skip to main content

Nucleic acid binding affinity and kinetics, from aptamers to ASOs

Aptamers, ASOs, and siRNA bind weakly and dissociate fast, and the numbers shift with immobilisation chemistry. Label-free analysis of nucleic acids has to hold up under both, and under modified backbones that bind surfaces non-specifically.
Sensitive detection at 0.1 RU RMS baseline noise
Affinity range from 10 pM to 10 mM
From 30 µL of sample per injection

Where nucleic acid researchers use label-free binding data

Label-free interaction analysis measures binding between unmodified molecules in real time. For nucleic acids it returns affinity (KD), association and dissociation rates, and specificity against mismatch and scrambled controls, with no fluorophore or reporter on the sequence.

Aptamer characterisation

Rank the sequences that come out of a selection round.

Measure affinity and off-rate for each candidate against the same target.

aptamer KD

Modified oligonucleotides

Work with phosphorothioate, LNA, and 2'-modified chemistries.

Compare binding across backbone modifications on one surface.

gRNA siRNA ASO

Nucleic acid and protein interactions

Measure how DNA-binding and RNA-binding proteins engage their sites.

Titrate the protein against an immobilised sequence to get KD.

DNA-protein binding

Hybridisation and duplex formation

Follow a duplex forming as it happens.

Measure how fast a complementary strand anneals and comes apart.

hybridisation kinetics

Specificity and off-target profiling

Test the target sequence against its own controls.

Spot mismatch, scrambled, and off-target sequences alongside the target.

mismatch controls

Benefits of the inQuiQ in nucleic acid analysis

01 / 04

One injection, four channels, sixteen sensors

Four independently addressable channels with four sensors each, all reading one sample in series.

30 µL minimumsequential flow paths
In-flow immobilisation
Spotter immobilisation

Read binding that is over in seconds

The full injection is recorded, so fast-dissociating duplexes and aptamers are read while still bound.

0.1 RU RMS10 pM to 10 mM
fast off-rate, then baseline

Attach without burying the binding site

Capture and covalent coupling are both available, so the oligonucleotide attaches at the end that takes no part in binding.

  • Phosphorothioate, LNA, and 2'-modified backbones attach alike
  • One strategy per set, so candidates stay comparable
end capture, or direct coupling

Target, mismatch, and scrambled from one sample

Immobilise the target next to its mismatch, scrambled, and off-target controls, then inject once.

target
binds
single mismatch
reduced
scrambled
no binding
target, mismatch, scrambled

How a binding run works

Every measurement follows the same steps, whatever the sequence. One partner is held on the sensor, the other flows past, and the response is recorded through the whole injection rather than at the end.

Immobilisation

The oligonucleotide is attached to the sensor surface first.

For nucleic acid binding kinetics analysis, end capture or covalent coupling leaves the binding region free, whether the sequence is an aptamer, an ASO, or a CRISPR guide. Density is kept low enough that the measured rates reflect binding rather than transport to the surface.

  • streptavidin-biotin capture
  • amine coupling
  • ligand density

Deactivation

Unused activated sites are switched off before the first sample arrives.

Otherwise the surface keeps reacting with whatever passes over it, and non-specific binding appears in the sensorgram as signal unrelated to the sequence being measured.

  • deactivation
  • blocking
  • non-specific binding

Association

The binding partner flows across the surface and the response climbs.

Whether the injected partner is a complementary strand, a DNA-binding protein, or an aptamer target, the association phase gives the on-rate, kon, for hybridisation or for protein binding.

  • hybridisation
  • DNA-protein binding
  • kon

Dissociation

Buffer replaces the sample and the response falls as the duplex or complex comes apart.

The dissociation phase gives koff, and 1/koff gives complex lifetime. A concentration series gives kon, koff, and KD. Where dissociation is fast, plateau responses give steady-state aptamer affinity.

  • complex lifetime
  • koff
  • aptamer KD
  • steady state

Regeneration

A short denaturing wash strips the bound partner and returns the sensor to baseline.

The attached sequence stays in place, so every SELEX candidate or backbone variant meets the same surface across the screen.

  • regeneration
  • SELEX candidates
  • automated cycling
Response (RU) Time

What the inQuiQ does for nucleic acid research

Six capabilities, one modular benchtop instrument, in a label-free workflow.

Many sequences, one small sample

Four channels with in-flow immobilisation, or sixteen sensors with a spotter, compare candidates and controls from one injected sample.

16 sensors (spotter required) 30 µL

Hold onto fast-dissociating binders

Baseline noise stays low enough that a short-lived complex is still readable.

0.1 RU RMS

Weak duplexes through tight aptamers

One affinity range covers low-affinity hybridisation and high-affinity aptamers, with steady-state fitting when dissociation is too fast for kinetics.

10 pM to 10 mM

Immobilisation that fits the chemistry

Capture or covalent coupling attaches a modified backbone at the end that takes no part in binding.

capture covalent coupling

Tune contact time to the sample

Flow rate sets how long the sample meets the surface, which matters when the analyte is dilute. 1 to 100 µL/min, up to 300 µL/min for low-viscosity samples.

1 to 100 µL/min

Modular system for an increased throughput

Simply add an autosampler, and run a long sequence or condition series unattended.

2×96 wells 2×384 wells
Explore the inQuiQ768
Start A conversation

Talk to an application scientist

Bring your sequence. We will tell you honestly whether label-free is the right method for it, and how the assay would be built.

Ready to see the inQuiQ in action?

Questions researchers ask

Immobilise the aptamer through an end tag, then inject the target across a concentration series. The association phase gives kon, the dissociation phase gives koff, and the two together give KD. On the inQuiQ affinity runs from 10 pM to 10 mM, and every candidate is measured on the same surface.

Attach the DNA sequence to the sensor and inject the protein as a dilution series. Binding is recorded in real time, so you get association and dissociation rates as well as KD. Neither partner carries a fluorophore, so the measured affinity is not shifted by a reporter group.

Often, yes. The response is recorded continuously through the injection, so a complex that lasts seconds is visible while it is bound rather than after it has gone. Where dissociation is too fast to fit kinetics, plateau responses across a concentration series give a steady-state affinity instead.

Either capture the sequence through an end tag or couple it to the surface chemistry directly. Phosphorothioate, LNA, and 2'-modified backbones are attached the same way. Attach the end that takes no part in binding, so the site stays free and the measured rates stay meaningful.

Spot the target sequence next to mismatch, scrambled, and off-target controls on one chip, using up to sixteen sensors with a spotter. One sample is then injected and flows through the channels in series, so every control meets the same material under the same conditions.